Company Overview and News

2
Broadcom Inc. (AVGO) Gains As Market Dips: What You Should Know

2018-10-19 zacks
Broadcom Inc. (AVGO - Free Report) closed the most recent trading day at $228.28, moving +0.11% from the previous trading session. The stock outpaced the S&P 500's daily loss of 0.04%. At the same time, the Dow added 0.26%, and the tech-heavy Nasdaq lost 0.48%.
BLT BHP BCBP BHPBF AVGO SDPI BBL BHP SPDI BRCM BHPLF

34
Xilinx: Nvidia's Next Big AI Rival

2018-10-19 seekingalpha - 1
The new chips target the AI inference market, one that is expected to grow bigger than the AI training market that Nvidia currently dominates.
XLNX BCS GOOGL AVGO AMD NVDA GOOG BRCM QCOM INTC

2
Broadcom gets final antitrust approval, clearing way for CA acquisition

2018-10-13 marketwatch - 1
Broadcom Inc. AVGO, +1.77% said late Friday it received approval from European authorities for its acquisition of CA Inc. CA, +0.53% In a filing with the Securities and Exchange Commission, Broadcom said the antitrust clearance from the European Union was the last hurdle to close the deal after having received approval from Japanese regulators on Oct. 2. Broadcom said it expects to close the deal by Nov.
AVGO CAIAF BRCM CA

12
Market Extra: These are the stocks that options investors are most worried about

2018-10-11 marketwatch - 2
Fear and volatility returned to the U.S. stock market in a big way over the past several sessions, but concerns over bond yields, trade policy and other factors aren’t spread evenly across the economy. Instead, there are a few names that investors see as particularly risky.
ACAD FEYE INFN GOOGL AVGO GOOG BRCM HRI HTZ CMG

1
Resonant Inc. Appoints Tech and Finance Executive Bob Tirva to its Board of Directors

2018-10-11 globenewswire
GOLETA, Calif., Oct. 11, 2018 (GLOBE NEWSWIRE) -- Resonant Inc. (NASDAQ: RESN), a leader in transforming the way radio frequency, or RF, front-ends are being designed and delivered for wireless devices, announced its board of directors has appointed Bob Tirva to serve as a board member, increasing its total number of directors to 10.
AVGO BRCM RESN

5
Pentagon says memo asking for Broadcom-CA deal review is likely fake

2018-10-10 reuters
(Reuters) - The U.S. Department of Defense said on Wednesday that a memo purporting to show the Pentagon asking for a national security review of chipmaker Broadcom Inc’s (AVGO.O) $19 billion deal to buy software company CA Technologies (CA.O) was likely fake.
AVGO BRCM QCOM

8
Qualcomm adds two new members to its board

2018-10-09 reuters
(Reuters) - Qualcomm Inc said on Tuesday it named Martin Anstice, chief executive officer of chip gear maker Lam Research Corp, and Irene Rosenfeld, former chairman and CEO of U.S. snack foods company Mondelez International Inc, to its board.
LRCX AVGO AAPL MDLZ BRCM QCOM

8
Qualcomm adds two new members to its board

2018-10-09 channelnewsasia
Qualcomm Inc said on Tuesday it named Martin Anstice, chief executive officer of chip gear maker Lam Research Corp, and Irene Rosenfeld, former chairman and CEO of U.S. snack foods company Mondelez International Inc, to its board.
LRCX AVGO AAPL MDLZ BRCM QCOM

1
Broadcom Inc. (AVGO) Dips More Than Broader Markets: What You Should Know

2018-10-08 zacks
Broadcom Inc. (AVGO - Free Report) closed at $241.37 in the latest trading session, marking a -1.22% move from the prior day. This move lagged the S&P 500's daily loss of 0.04%. At the same time, the Dow added 0.15%, and the tech-heavy Nasdaq lost 0.67%.
FCN AVGO BRCM

2
Top 5 ROE Stocks to Buy as Markets Brace for Q3 Earnings

2018-10-08 zacks
The U.S. equity markets remained highly volatile over the past week as yields from the treasury bonds inched up with solid macroeconomic fundamentals. Per the latest jobs report, unemployment rate declined to a 49-year low of 3.7%, fuelling speculations of a likely Fed hike later this year and up to four times in 2019. With the earnings season set to gradually pick up pace in the forthcoming weeks, the markets are anticipated to witness another round of volatility owing to lesser-than-expected performance from the banking sector.
CBG AVGO PGR WM BRCM CBRE CE

1
Broadcom Extends Automotive Ethernet Leadership with New Innovative Gigabit-capable PHY, Secure Switch and Smart Camera MCU

2018-10-08 globenewswire
SAN JOSE, Calif., Oct. 08, 2018 (GLOBE NEWSWIRE) -- Broadcom Inc. (NASDAQ: AVGO) today announced its latest portfolio of automotive Ethernet devices designed to advance in-vehicle connectivity, infotainment, advanced driver assistance systems (ADAS) and smart mobility. With more than 50 million automotive 100BASE-T1 BroadR-Reach® PHY and switch Ethernet ports shipped and growing, Broadcom expands its portfolio with the addition of 1000BASE-T1 PHY, secure switch and smart camera MCU devices to address new and emerging applications.
AVGO BRCM

2
Broadcom Inc. (AVGO) Up 13.1% Since Last Earnings Report: Can It Continue?

2018-10-06 zacks
It has been about a month since the last earnings report for Broadcom Inc. (AVGO - Free Report) . Shares have added about 13.1% in that time frame, outperforming the S&P 500.
HD AVGO BRCM GWRE

38
The Ratings Game: Chip stocks hit worst as tech selloff drags broader market lower

2018-10-05 marketwatch - 2
Chip-related stocks fell Friday as the subsector got hit the hardest in a tech-stocks selloff, significantly widening its underperformance to the broader market for the year.
MRVL QRVO CY TXN CRUS AMD NVDA SWKS AAPL AVGO ADI BRCM INTC MXIM

9
Technology And Communication Dashboard - Update

2018-10-05 seekingalpha - 1
This article series provides a monthly dashboard of industries in each sector of the GICS classification. It compares valuation and quality factors relative to their historical averages in each industry.
VIA GLW VIAB AVGO BRCM ATVI

1
SMART Global Holdings Reports Fourth Quarter and Full Year Fiscal 2018 Financial Results

2018-10-04 globenewswire
NEWARK, Calif., Oct. 04, 2018 (GLOBE NEWSWIRE) -- SMART Global Holdings, Inc. (“SMART”) (NASDAQ: SGH), parent company of SMART Modular Technologies, Inc., today reported financial results for the fourth quarter and full year fiscal 2018 ended August 31, 2018.
AVGO BRCM SGH

Related Articles

ALIM: Alimera Sciences Analysis and Research Report

2018-10-01 - Asif

Overview The following discussion and analysis should be read in conjunction with its unaudited interim condensed consolidated financial statements and the related notes that appear elsewhere in this quarterly report on Form 10-Q. This discussion contains forward-looking statements reflecting its current expectations that involve risks and uncertainties. Actual results may differ materially from those discussed in these forward-looking statements due to a number of factors, including those set forth in the section entitled “Risk Factors” in its most recent annual report on Form 10-K. For further information regarding forward-looking statements, please refer to the “Special Note Regarding Forward-Looking Statements and Projections” immediately after the index to this quarterly report on Form 10-Q. Alimera Sciences, Inc., and its subsidiaries (we or Alimera), is a pharmaceutical company that specializes in the commercialization and development of prescription ophthalmic pharma...

DMPI: DelMar Pharmaceuticals Analysis and Research Report

2018-09-25 - Asif

Background DelMar Pharmaceuticals, Inc. is a clinical stage drug development company with a focus on the treatment of cancer. The company's mission is to benefit patients and create shareholder value by developing and commercializing anti-cancer therapies for patients whose tumors exhibit features that make them resistant to, or unlikely to respond to, currently available therapies, particularly for orphan cancer indications where patients have failed, or are unlikely to respond to, currently available therapy. DelMar Pharmaceuticals is developing VAL-083, a novel, DNA-targeting agent, for the treatment of glioblastoma multiforme (“GBM”) and potentially other solid tumors, including ovarian cancer. VAL-083 is a first-in-class, DNA-targeting chemotherapeutic that demonstrated activity against a range of tumor types in prior Phase 1 and Phase 2 clinical studies sponsored by the US National Cancer Institute (“NCI”). The company's recent research has highlighted the opportunit...

RIGL: Rigel Pharmaceuticals Analysis and Research Report

2018-09-18 - Asif

Overview Rigel Pharmaceuticals is a biotechnology company dedicated to discovering, developing and providing novel small molecule drugs that significantly improve the lives of patients with immune and hematologic disorders, cancer and rare diseases. The company's pioneering research focuses on signaling pathways that are critical to disease mechanisms. The company's first FDA-approved product is TAVALISSE™ (fostamatinib disodium hexahydrate), an oral spleen tyrosine kinase (SYK) inhibitor, for the treatment of adult patients with chronic immune thrombocytopenia who have had an insufficient response to a previous treatment. The company's current clinical programs include Phase 2 studies of fostamatinib in autoimmune hemolytic anemia and IgA nephropathy, and a Phase 1 study for its IRAK program. In addition, Rigel Pharmaceuticals has product candidates in development with partners BerGenBio AS, Daiichi Sankyo, and Aclaris Therapeutics. Since inception, Rigel Pharmaceuticals h...

Silicon Investor Message Boards

This table lists all message boards related to BRCM / Broadcom Corporation on message board site Silicon Investor.

Broadcom (BRCM) Broadcom (BRCM) Broadcom (BRCM) Tech Clowns Only...No doom and gloom Tech Clowns Only...No doom and gloom Tech Clowns Only...No doom and gloom
MAKR: the next BRCM? MAKR: the next BRCM? MAKR: the next BRCM? BROADCOM (BRCM) - upcoming IPO BROADCOM (BRCM) - upcoming IPO BROADCOM (BRCM) - upcoming IPO
CUSIP: 111320107